Prelude Therapeutics（PRLD.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

风投/私募30.64%
公众及其他23.71%
机构投资者20.23%
对冲基金16.79%
其他8.62%

主要股东

主要股东最新
股东
OrbiMed Advisors LLC	24.36%	2,508.49 万	4.26%	+849.55 万	2026/06/30
Baker Bros. Advisors LP	16.79%	1,729.39 万	4.92%	-63.07 万	2026/06/30
RA Capital Management, L.P.	6.29%	647.59 万	--	+647.59 万	2026/06/30
Incyte Corporation	4.24%	437.21 万	1.05%	+0	2025/11/03
Soleus Capital Management, L.P.	3.28%	337.84 万	--	+337.84 万	2026/06/30
Krishna VaddiFounder, CEO & Director	3.03%	311.73 万	0.75%	+0	2025/12/31
Kynam Capital Management, LP	2.34%	241.51 万	0.42%	+82.25 万	2026/06/30
Vanguard Capital Management, LLC	2.23%	229.43 万	0.55%	+90.65 万	2026/06/30
BlackRock, Inc.	1.75%	179.75 万	1.36%	+147.56 万	2026/06/30
Sphera Funds Management Ltd	0.99%	101.98 万	0.31%	+46.15 万	2026/06/30
Two Sigma Investments, LP	0.96%	99.34 万	0.15%	+6.97 万	2026/06/30
ADAR1 Capital Management, LLC	0.87%	90.09 万	0.69%	+74.81 万	2026/06/30
Millennium Management LLC	0.82%	84.50 万	0.36%	+46.23 万	2026/06/30
Geode Capital Management, LLC	0.82%	84.19 万	0.45%	+53.94 万	2026/06/30
Adage Capital Management, L.P.	0.74%	76.61 万	--	+76.61 万	2026/06/30
Soleus Capital LLC	0.66%	67.57 万	--	+67.57 万	2026/04/21
Acadian Asset Management LLC	0.59%	61.14 万	0.03%	+9.98 万	2026/06/30
Blue Sky Trust	0.54%	55.18 万	0.13%	+0	2025/12/31
Paul FriedmanIndependent Chairman of the Board	0.49%	50.01 万	0.12%	+0	2025/03/31
Andrew CombsExecutive VP & Chief Chemistry Officer	0.47%	48.01 万	0.12%	+0	2025/03/31